Apply for a grant

Learn more about the research we fund and our research strategy.

Announcing 2025 Research Grant Opportunities!

In 2025 PanKind will provide funding competitive and strategic opportunities throughout the calendar year. Our next grant opportunity will be competitive grants across the early detection and new treatment schemes. Innovator and accelerator schemes will be introduced across the New Treatment Category, to cater for both emerging and more developed research. 

Grant Category	Funding per Grant Category	Funding Period	Funding Round Opens
Early Detection Innovation Grant	$100,000	1 Year	May 2025
New Treatment Accelerator Grant	$100,000	1 Year	May 2025
New Treatment Accelerator Grant	$200,000	2 Years	May 2025

 

 

 

 

 

 

 

2025 Research Grants Timeline

Wednesday the 18 December Grant information posted online 

Monday 5 May Call for Applications for Innovation and Accelerator Grant Applications

Monday 28 July 2024 Closing date for submission of Grant Applications (submissions will not be accepted after 5pm (AEST))

Grant Outcome Announced Publicly October 2025

 

→ Early Detection Innovation Grant

Funding available: $100K grant for 1 year. 

The Early Detection Grant will provide funding to Australian researchers to:

• encourage new strategies to detect, diagnose and manage pancreatic cancer earlier,
• support established and/or early career researchers to develop preliminary data and attract additional funding in subsequent years. 

Criteria for funding: 

• Applications should demonstrate solid rationale and extensive planning 
• Proof-of-concept or exploratory data to demonstrate the feasibility and rationale for your research questions should be detailed sufficiently
• Only one application per institution may be submitted for each scheme
• International collaborations are encouraged if the PI is located in Australia
  
  Eligible projects may include:
• Computational tools, machine learning approaches or large language models to generate actionable insights 
• Imaging studies
• Repurposing or adapting tools and methods from other diseases
• Approaches aimed at enhancing current standards of care
• Investigation of high risk individuals or groups
  

→ New Treatment Innovation Grant

Funding available: $100K grant for 1 year.

The New treatment Innovation Grant will provide funding to Australian researchers to:

• Carry out projects at an early stage that will accelerate development of new treatments, diagnostics or quality (including standard of care) to pancreatic cancer patients,
• Support established and/or early career researchers to develop preliminary data and attract additional funding in subsequent years,
• Accelerate research translation. 

Criteria for funding

• Applications should demonstrate solid rationale and extensive planning 
• Proof-of-concept or exploratory data to demonstrate the feasibility and rationale for your research questions should be detailed sufficiently
• Where applications have multiple AI’s, the role of each co-investigator must be outlined and justified 
• Only one application per institution may be submitted for each scheme 
•  International collaborations are encouraged if the PI is located in Australia. 

These projects should explore innovative solutions that have the potential to significantly advance the therapeutic field.

→ New Treatment Accelerator Grant 

Funding available: $200k grant over 2 years, focused on accelerating treatments for pancreatic cancer to patients.

The New Treatment Grant will provide funding to Australian researchers to: 

• carry out projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients, 
• innovative projects that require resources to advance critical milestones, 
• extend previous or existing work for a new treatment, 
• grow capacity in pancreatic cancer research in Australia,
• accelerate the translation of promising therapies to clinical application; and
• improve survival from pancreatic cancer in line with our mission to triple survival by 2030.
•  International collaborations are encouraged if the PI is located in Australia. 

Criteria for funding

• Projects which are more developed, part of a larger program of work,  and have early preliminary data may be suited to this scheme 
• Pilot or preliminary data should be developed and detailed as relevant to the application 
• Eligible projects may include early-mid stage exploratory studies, scaling up existing research, or addressing urgent scientific challenges.
• Where applications have multiple AI’s, the role of each co-investigator must be outlined and justified
• Only one application per institution may be submitted for each scheme. 

Eligibility

PanKind will only fund projects where:

1. Only one application per institution may be submitted for each scheme. 
2. The administering institution agrees to the terms and conditions of funding as outlined on this page and in PanKind’s Research Funding Agreement. Please note amendments to the agreement terms are generally not accepted, so please ensure the agreement is reviewed prior to submitting your application.
3. The application has been submitted using PanKind's Grant Application Form (will be available early in 2025). 
4. The grant applicant (Principal Investigator) resides in Australia.
5. The grant applicant’s administering institution is an Australian organisation.
6. The applicant is the Principal Investigator on no more than one application across all grant categories.
7. The applicant and research team members are each funded at a maximum of 1 full-time equivalent.
8. If, at the time of application you currently hold a PanKind grant as a Principal Investigator, your grant will finish within the current calendar year. Please note we reserve the right to alter or withdraw our offer of award if you do not fulfil the requirements of your currently held grant.
9. Biotechnology, pharmaceutical or other relevant companies may apply for funding, however, if successful PanKind may vary the terms of funding. 

If you would like to discuss which grant category your application may be best suited to please email us on grants@pankind.org.au 

In 2025 an Early Detection Grant will be named the Marianne Allan Pancreatic Research Grant in honour of Marianne Allan. Marianne and Ross Allan are dedicated to helping improve outcomes through detecting pancreatic cancer earlier.

Learn more about them and their incredible contribution here.

Grant Assessment Criteria 

All applications will be assessed by the Scientific Advisory Panel and selected experts, according to the following criteria:

1. Investigator team capability

2. Novelty of the project. The novelty of concept, originality, and innovation

3. Impact. Potential to improve pancreatic cancer survival

4. Quality and feasibility. Scientific quality and feasibility of the proposed project and/or rationale

5. Budget

Read our Conflict of Interest Policy. 

If you have any questions about our grants or would like more information about our grant application process, please email grants@pankind.org.au.